Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
about
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@en
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@nl
type
label
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@en
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@nl
prefLabel
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@en
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P1433
P1476
Neoadjuvant degarelix with or ...... ind, placebo-controlled trial.
@en
P2093
Annouschka Laenen
Christine Buerki
Christine Decaestecker
Frank Claessens
Gert De Meerleer
Isabelle Salmon
Johan Swinnen
Karin Haustermans
Karolien Goffin
Lisa Moris
P2860
P2888
P356
10.1186/S12885-018-4275-Z
P407
P577
2018-04-02T00:00:00Z
P6179
1101892354